Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Virosomal adjuvanted antigen delivery systems.

Christian Moser1, Ian C Metcalfe, Jean-François Viret

  • 1Virology, Berna Biotech Ltd, Bern, Switzerland.

Expert Review of Vaccines
|August 6, 2003
PubMed
Summary

Virosomal vaccines represent a significant advancement in vaccinology, effectively enhancing antigen immunogenicity. These advanced vaccine formulations stimulate robust humoral and cellular immune responses with minimal side effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnostic accuracy of biopsy after neoadjuvant treatment for well-differentiated and dedifferentiated retroperitoneal liposarcoma.

Surgical oncology·2023
Same author

A clinically applicable gene expression-based score predicts resistance to induction treatment in acute myeloid leukemia.

Blood advances·2021
Same author

Frequency of Polyps and Adenocarcinoma in Colon Interposition After Esophagectomy in Adulthood - A Systematic Review.

Anticancer research·2019
Same author

ZIEL: Internet-Based Self-Help for Adjustment Problems: Results of a Randomized Controlled Trial.

Journal of clinical medicine·2019
Same author

International collaboration generates high quality clusters of pharmaceutical patents.

Pharmaceutical patent analyst·2019
Same author

Patents as Early Indicators of Technology and Investment Trends: Analyzing the Microbiome Space as a Case Study.

Frontiers in bioengineering and biotechnology·2018

Area of Science:

  • Vaccinology
  • Immunology
  • Biotechnology

Background:

  • Developing safer vaccines often uses purified proteins or peptides as antigens.
  • These antigens can be poor immunogens when administered alone, necessitating the use of adjuvants.
  • Adjuvants enhance antigen immunogenicity with minimal side effects.

Purpose of the Study:

  • To discuss virosomal vaccines as a successful advancement in vaccinology.
  • To explain the principles, immunoadjuvant action, and applications of virosomes.
  • To highlight the induction of humoral and cellular immunity by virosomal vaccines.

Main Methods:

  • Review of virosomal vaccine technology.
  • Analysis of immunoadjuvant mechanisms.
  • Case studies of two licensed virosomal vaccines.

Main Results:

  • Virosomal vaccines are a successful vaccinology approach.
  • Virosomes act as effective immunoadjuvants.
  • Licensed virosomal vaccines induce both humoral and cellular immunity.

Conclusions:

  • Virosomal vaccines offer a promising strategy for enhancing vaccine efficacy.
  • The technology effectively addresses the challenge of poor antigen immunogenicity.
  • Virosomes contribute to the induction of comprehensive immune responses.

Related Experiment Videos